MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    The association of CSF sTREM2 with cognitive decline and its dynamic change in Parkinson’s disease: Analysis of the PPMI Cohort

    Q. Qixiong, W. Hengming, W. Danlei, L. Jingyi, Q. Yi, Z. Jingwei, L. Jiangting (Wu han, China)

    Objective: This study aims to investigate the baseline and longitudinal changes of soluble fragments of triggering receptor expressed on myeloid cells 2 (sTREM2) in cerebrospinal…
  • 2022 International Congress

    Detection and Analysis of Spatio-Temporal Variables of Parkinsonian Gait Using PODOSmart® Insoles

    E. Ziagkas, A. Loukovitis, S. Bostantjopoulou, Z. Katsarou, G. Grouios (Thessaloniki, Greece)

    Objective: Objective: Typical Parkinsonian gait detection and analysis is heavily dependent on expensive sensors and human labor. Here we propose the use of PODOSmart® insoles,…
  • 2022 International Congress

    sleep disturbance and wakefulness in parkinson’s disease

    A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)

    Objective: a complete study of sleep disorders and their adequate treatment Background: Sleep and wake disturbances are the second most common non-motor symptom of Parkinson's…
  • 2022 International Congress

    Manifestations of Parkinson’s Disease in different ethnicities in Sumatera Indonesia: A Descriptive Study

    S. Marisdina, S. Handayani, Y. Diansari, A. Afriani, R. Odiesta, M. Nur'Aini (Palembang, Indonesia)

    Objective: To describe manifestations of Parkinson’s Disease (PD) in different ethnicities in Sumatera, Indonesia. Background: Prevalence of PD is varied around the world. Some studies…
  • 2022 International Congress

    Visual system abnormalities and visual hallucinations in Parkinson’s disease

    M. Diez-Cirarda, A. Cabrera, A. Murueta-Goyena, A. Strafella, R. Del Pino, MA. Acera, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: We aimed to identify clinical and imaging biomarkers of visual system injury associated with the presence of Visual hallucinations (VH) in Parkinson's disease (PD).…
  • 2022 International Congress

    Alterations in neuron-derived exosomal cargo in Parkinson Disease

    V. Gorgogietas, IB. Boussaad, F. Borgmann, M. Mittelbronn, R. Krueger (Esch-sur-Alzette, Luxembourg)

    Objective: The main objectives are 1) the confirmation of exosome isolation, based on iPSC-derived midbrain neuron model, 2) the identification of α-synuclein cargo of PD-patient…
  • 2022 International Congress

    Type 2 diabetes-associated transcriptomic changes in Parkinson’s disease and non-neurodegenerative control brains.

    P. Cullinane, E. de Pablo-Fernandez, K. Ebanks, Z. Jaunmuktane, T. Warner (London, United Kingdom)

    Objective: To evaluate the effect of type 2 diabetes (T2D) on gene transcription in Parkinson’s disease (PD) and non-neurodegenerative control brains. Background: People with T2D…
  • 2022 International Congress

    Neurophysiological and Clinical Effects of Low-intensity Transcranial Ultrasound of the Motor Cortex in Parkinson’s Disease

    T. Grippe, Y. Shamli Oghli, G. Darmani, T. Arora, C. Sarica, C. Rinchon, J. Nankoo, C. Gunraj, R. Chen (Toronto, Canada)

    Objective: Evaluate the neurophysiological and clinical effects of transcranial ultrasound stimulation (TUS) of motor cortex (M1) in PD patients. Background: Low-intensity TUS is a novel,…
  • 2022 International Congress

    Validity and reliability of the Thai version of the Freezing of Gait Questionnaire (FOG-Q) in individuals with Parkinson’s disease (PD)

    A. Taweekitikul, P. Tanvijit (Bangkok, Thailand)

    Objective: To evaluate the validity and reliability of the Thai version of FOG-Q (Thai FOG-Q) in individuals with PD. Background: Freezing of gait (FOG) is…
  • 2022 International Congress

    Exploratory delayed-start analysis of PASADENA evaluating the efficacy of prasinezumab on motor progression and motor complications in early-stage Parkinson’s disease

    G. Pagano, S. Zanigni, A. Monnet, K. Taylor, A. Hahn, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, H. Svoboda, P. Fontoura, R. Doody, G. Kerchner, A. Bonni, T. Nikolcheva (Basel, Switzerland)

    Objective: To evaluate the effect of prasinezumab on motor progression and motor complications in early-stage Parkinson’s disease (PD) using an exploratory delayed-start analysis of Part…
  • « Previous Page
  • 1
  • …
  • 237
  • 238
  • 239
  • 240
  • 241
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley